As of 2026-01-07, the Relative Valuation of Sensei Biotherapeutics Inc (SNSE) is (343.88) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.88 USD, the upside of Sensei Biotherapeutics Inc based on Relative Valuation is -3260.7%.
The range of the Relative Valuation is (277.41) - (370.13) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 19.3x | 17.8x |
| Forward P/E multiples | 14.5x - 21.7x | 18.1x |
| Fair Price | (277.41) - (370.13) | (343.88) |
| Upside | -2649.7% - -3501.9% | -3260.7% |
| Date | P/E |
| 2025-12-31 | -0.56 |
| 2025-12-30 | -0.46 |
| 2025-12-29 | -0.47 |
| 2025-12-26 | -0.47 |
| 2025-12-24 | -0.48 |
| 2025-12-23 | -0.48 |
| 2025-12-22 | -0.50 |
| 2025-12-19 | -0.46 |
| 2025-12-18 | -0.48 |
| 2025-12-17 | -0.44 |
| 2025-12-16 | -0.42 |
| 2025-12-15 | -0.41 |
| 2025-12-12 | -0.45 |
| 2025-12-11 | -0.47 |
| 2025-12-10 | -0.45 |
| 2025-12-09 | -0.42 |
| 2025-12-08 | -0.43 |
| 2025-12-05 | -0.51 |
| 2025-12-04 | -0.55 |
| 2025-12-03 | -0.45 |
| 2025-12-02 | -0.43 |
| 2025-12-01 | -0.44 |
| 2025-11-28 | -0.44 |
| 2025-11-26 | -0.44 |
| 2025-11-25 | -0.45 |
| 2025-11-24 | -0.47 |
| 2025-11-21 | -0.46 |
| 2025-11-20 | -0.46 |
| 2025-11-19 | -0.52 |
| 2025-11-18 | -0.45 |
| 2025-11-17 | -0.42 |
| 2025-11-14 | -0.42 |
| 2025-11-13 | -0.47 |
| 2025-11-12 | -0.53 |
| 2025-11-11 | -0.50 |
| 2025-11-10 | -0.50 |
| 2025-11-07 | -0.47 |
| 2025-11-06 | -0.49 |
| 2025-11-05 | -0.46 |
| 2025-11-04 | -0.45 |
| 2025-11-03 | -0.45 |
| 2025-10-31 | -0.48 |
| 2025-10-30 | -0.49 |
| 2025-10-29 | -0.49 |
| 2025-10-28 | -0.50 |
| 2025-10-27 | -0.53 |
| 2025-10-24 | -0.55 |
| 2025-10-23 | -0.55 |
| 2025-10-22 | -0.56 |
| 2025-10-21 | -0.58 |